Reactive oxygen species involved in CT26 immunogenic cell death induced by Clostridium difficile toxin B

Immunology Letters

Volumn 164, Issue 2, 2015, Pages 65-71

  Sun, Chunli ^a   Wang, Haiying ^a   Mao, Shuang ^a   Liu, Ji ^a   Li, Shan ^a   Wang, Jufang ^a  

^a SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Apoptosis; Clostridium difficile toxin B; Immunogenic cell death; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATE; ANTIMYCIN A1; CALRETICULIN; CLOSTRIDIUM DIFFICILE TOXIN B; DIPHENYLIODONIUM SALT; DNA; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HIGH MOBILITY GROUP B1 PROTEIN; MITOMYCIN; MITOXANTRONE; REACTIVE OXYGEN METABOLITE; STAUROSPORINE; BACTERIAL PROTEIN; BACTERIAL TOXIN; RECOMBINANT PROTEIN; TOXB PROTEIN, CLOSTRIDIUM DIFFICILE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CELL DEATH; CELL SURFACE; CONTROLLED STUDY; DNA CONTENT; DNA DETERMINATION; FEMALE; FLUORESCENCE ANALYSIS; IMMUNOCOMPETENT CELL; IMMUNOGENIC CELL DEATH; MOUSE; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; PROTEIN SECRETION; TUMOR IMMUNITY; TUMOR VOLUME; DRUG EFFECTS; HUMAN; IMMUNOLOGY; METABOLISM; TUMOR CELL LINE;

APOPTOSIS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CELL DEATH; CELL LINE, TUMOR; HUMANS; REACTIVE OXYGEN SPECIES; RECOMBINANT PROTEINS;

EID: 84924613494     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2015.02.007     Document Type: Article

References (44)

1. Dudek A.M., Garg A.D., Krysko D.V., De Ruysscher D., Agostinis P. Inducers of immunogenic cancer cell death. Cytokine Growth Factor Rev 2013, 24:319-333.
2. Garrido G., Rabasa A., Sánchez B., López M.V., Blanco R., López A., et al. Induction of immunogenic apoptosis by blockade of epidermal growth factor receptor activation with a specific antibody. J Immunol 2011, 187:4954-4966.
3. Menger L., Vacchelli E., Adjemian S., Martins I., Ma Y., Shen S., et al. Cardiac glycosides exert anticancer effects by inducing immunogenic cell death. Sci Transl Med 2012, 4:143ra99.
4. Panaretakis T., Kepp O., Brockmeier U., Tesniere A., Bjorklund A.-C., Chapman D.C., et al. Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. EMBO J 2009, 28:578-590.
5. Aymeric L., Apetoh L., Ghiringhelli F., Tesniere A., Martins I., Kroemer G., et al. Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity. Cancer Res 2010, 70:855-858.
6. Extracellular A. Autophagy-dependent ATP release from dying cells via lysosomal exocytosis. Autophagy 2013, 9:1624-1625.
7. Feng H., Zeng Y., Whitesell L., Katsanis E. Stressed apoptotic tumor cells express heat shock proteins and elicit tumor-specific immunity. Blood 2001, 97:3505-3512.
8. Galluzzi L., Kepp O., Kroemer G. Enlightening the impact of immunogenic cell death in photodynamic cancer therapy. EMBO J 2012, 31:1055-1057.
9. Garg A.D., Krysko D.V., Vandenabeele P., Agostinis P. The emergence of phox-ER stress induced immunogenic apoptosis. Oncoimmunology 2012, 1:786-788.
10. Garg A.D., Krysko D.V., Verfaillie T., Kaczmarek A., Ferreira G.B., Marysael T., et al. A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. EMBO J 2012, 31:1062-1079.
11. Martins I., Michaud M., Sukkurwala A.Q., Adjemian S., Ma Y., Shen S., et al. Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death. Autophagy 2012, 8:413-415.
12. Zitvogel L., Kepp O., Senovilla L., Menger L., Chaput N., Kroemer G. Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway. Clin Cancer Res 2010, 16:3100-3104.
13. Green D.R., Ferguson T., Zitvogel L., Kroemer G. Immunogenic and tolerogenic cell death. Nat Rev Immunol 2009, 9:353-363.
14. Martins I., Wang Y., Michaud M., Ma Y., Sukkurwala A., Shen S., et al. Molecular mechanisms of ATP secretion during immunogenic cell death. Cell Death Differ 2014, 21:79-91.
15. Harding H.P., Novoa I., Zhang Y., Zeng H., Wek R., Schapira M., et al. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell 2000, 6:1099-1108.
16. Matarrese P., Falzano L., Fabbri A., Gambardella L., Frank C., Geny B., et al. Clostridium difficile toxin B causes apoptosis in epithelial cells by thrilling mitochondria. Involvement of ATP-sensitive mitochondrial potassium channels. J Biol Chem 2007, 282:9029-9041.
17. Kim H., Rhee S.H., Pothoulakis C., LaMont J.T. Inflammation and apoptosis in Clostridium difficile enteritis is mediated by PGE 2 up-regulation of Fas ligand. Gastroenterology 2007, 133:875-886.
18. Gerhard R., Nottrott S., Schoentaube J., Tatge H., Olling A., Just I. Glucosylation of Rho GTPases by Clostridium difficile toxin A triggers apoptosis in intestinal epithelial cells. J Med Microbiol 2008, 57:765-770.
19. Huang T., Li S., Li G., Tian Y., Wang H., Shi L., et al. Utility of Clostridium difficile toxin B for inducing anti-tumor immunity. PLOS ONE 2014, 9:e110826.
20. Kim H., Rhee S.H., Kokkotou E., Na X., Savidge T., Moyer M.P., et al. Clostridium difficile toxin A regulates inducible cyclooxygenase-2 and prostaglandin E2 synthesis in colonocytes via reactive oxygen species and activation of p38 MAPK. J Biol Chem 2005, 280:21237-21245.
21. Farrow M.A., Chumbler N.M., Lapierre L.A., Franklin J.L., Rutherford S.A., Goldenring J.R., et al. Clostridium difficile toxin B-induced necrosis is mediated by the host epithelial cell NADPH oxidase complex. Proc Natl Acad Sci U S A 2013, 110:18674-18679.
22. Li Y., Trush M.A. Diphenyleneiodonium, an NAD (P) H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production. Biochem Biophys Res Commun 1998, 253:295-299.
23. Kim H., Rhee S.H., Kokkotou E., Na X., Savidge T., Moyer M.P., et al. Clostridium difficile toxin A regulates inducible COX-2 and PGE2 synthesis in colonocytes via reactive oxygen species and activation of p38 MAP kinase. J Biol Chem 2005, 280:21237-21245.
24. O'Malley Y., Fink B.D., Ross N.C., Prisinzano T.E., Sivitz W.I. Reactive oxygen and targeted antioxidant administration in endothelial cell mitochondria. J Biol Chem 2006, 281:39766-39775.
25. Yang G., Zhou B., Wang J., He X., Sun X., Nie W., et al. Expression of recombinant Clostridium difficile toxin A and B in Bacillus megaterium. BMC Microbiol 2008, 8:192.
26. LeBel C.P., Ischiropoulos H., Bondy S.C. Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 1992, 5:227-231.
27. Wang H., Joseph J.A. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic Biol Med 1999, 27:612-616.
28. Darzynkiewicz Z., Bruno S., Del Bino G., Gorczyca W., Hotz M., Lassota P., et al. Features of apoptotic cells measured by flow cytometry. Cytometry 1992, 13:795-808.
29. Ichimura Y., Kirisako T., Takao T., Satomi Y., Shimonishi Y., Ishihara N., et al. A ubiquitin-like system mediates protein lipidation. Nature 2000, 408:488-492.
30. Klionsky D.J., Cuervo A.M., Seglen P.O. Methods for monitoring autophagy from yeast to human. Autophagy 2007, 3:181.
31. Mizushima N. Methods for monitoring autophagy. Int J Biochem Cell Biol 2004, 36:2491-2502.
32. Mizushima N., Yoshimori T. How to interpret LC3 immunoblotting. Autophagy 2007, 3:542.
33. Obeid M., Tesniere A., Ghiringhelli F., Fimia G.M., Apetoh L., Perfettini J.-L., et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 2007, 13:54-61.
34. Circu M.L., Aw T.Y. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 2010, 48:749-762.
35. Ray P.D., Huang B.-W., Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 2012, 24:981-990.
36. Schulz F., Just I., Genth H. Prevention of Clostridium sordellii lethal toxin-induced apoptotic cell death by tauroursodeoxycholic acid. Biochemistry 2009, 48:9002-9010.
37. Irani K. Oxidant signaling in vascular cell growth, death, and survival a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res 2000, 87:179-183.
38. Hagemann T., Balkwill F., Lawrence T. Inflammation and cancer: a double-edged sword. Cancer Cell 2007, 12:300-301.
39. Almand B., Clark J.I., Nikitina E., van Beynen J., English N.R., Knight S.C., et al. Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J Immunol 2001, 166:678-689.
40. Marigo I., Dolcetti L., Serafini P., Zanovello P., Bronte V. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol Rev 2008, 222:162-179.
41. Gajewski T.F., Meng Y., Harlin H. Immune suppression in the tumor microenvironment. J Immunother 2006, 29:233-240.
42. Apetoh L., Ghiringhelli F., Tesniere A., Obeid M., Ortiz C., Criollo A., et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 2007, 13:1050-1059.
43. Zhang B., Bowerman N.A., Salama J.K., Schmidt H., Spiotto M.T., Schietinger A., et al. Induced sensitization of tumor stroma leads to eradication of established cancer by T cells. J Exp Med 2007, 204:49-55.
44. Sun X., Savidge T., Feng H. The enterotoxicity of Clostridium difficile toxins. Toxins 2010, 2:1848-1880.